Market Research Logo

Global Antibody Drug Conjugates (ADC) Market – Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022) - By Region (N. America, Europe, APAC, RoW); By Country (US, Canada, UK, Germany, France, Japan, Chi

Global Antibody Drug Conjugates (ADC) Market – Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022) - By Region (N. America, Europe, APAC, RoW); By Country (US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa)

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Antibody Drug Conjugates Market on the basis of Analysis By Drug (Adcetris, Kadcyla), Pipeline Analysis (Developer, Phase, Indication, Status, Cytotoxic Payload, Linker, Target), By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan, Singapore, Brazil and South Africa).

Over the recent years, the global antibody drug conjugates industry has been growing rapidly as the global sales of Adcetris and Kadcyla have been witnessing rapid growth after their approval. Globally, the growth in the antibody drug conjugates market is driven by large number of ADC drugs in pipeline, rise in global incidences of cancer and wider therapeutic window offered by ADCs.

According to Azoth Analytics research report, “Global Antibody Drug Conjugates (ADC) Market – Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)”, global market is projected to display a robust growth represented by a CAGR of 21.82% during 2017 – 2022, chiefly driven by large number of ADC drugs in pipeline, rising number of cancer patients and wider therapeutic window offered by antibody drug conjugates.

Among the drugs, Kadcyla currently dominates the antibody drug conjugates market but will be surpassed by Adcetris in forecasted period. Among the regions, North America is predicted to advance at the highest rate, mainly driven by increase in several ADC molecules expected to gain FDA approval in next few years

The report titled, “Global Antibody Drug Conjugates (ADC) Market – Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)”, has covered and analysed the potential of Global Antibody Drug Conjugates Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)

  • Antibody Drug Conjugates Market (ADC) Market
  • Adcetris Market
  • Kadcyla Market
  • ADC Pipeline - By Developer, Phase, Indication and Status
  • ADC Pipeline - By Cytotoxic Payload, Linker and Target
Regional Markets – N. America, Europe, APAC, RoW (Actual Period: 2012-2016, Forecast Period: 2017-2022)
  • Antibody Drug Conjugates Market (ADC) Market
  • Adcetris Market
  • Kadcyla Market
  • ADC Pipeline - By Developer, Phase, Indication and Status
  • ADC Pipeline - By Cytotoxic Payload, Linker and Target
Country Analysis - US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa (Actual Period: 2012-2016, Forecast Period: 2017-2022)
  • Antibody Drug Conjugates Market (ADC) Market
  • Other Report Highlights:
  • Market Dynamics – Trends, Drivers, Challenges
  • Porter’s Five Forces Analysis
  • SWOT Analysis
  • Policy and Regulation
  • Company Analysis - Hoffmann-La Roche Ltd, Seattle Genetics, Takeda, ImmunoGen Inc, Pfizer Inc., Sanofi, AbbVie Inc, Cellldex Therapeutics, Synthon, Progenics Pharmaceuticals
Customization of the Report

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.


1. Research Methodology
2. Executive Summary
3. Strategic Recommendation
3.1 Focus on marketing ADCs at lower cost in Asia Pacific region
3.2 Multiple Licensing and Collaboration
3.3 Outsourcing of ADC manufacturing to CMOs
4. Antibody Drug Conjugates Product Overview
5. Global Antibody Drug Conjugates Market: Growth and Forecast
5.1 By Value (2012-2016)
Table 1: Global Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
5.2 By Value (2017-2022)
Table 2: Global Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Table 3: Estimated Incidences of Global Cancer Cases, By percent, 2012
Table 4: Estimated Incidences of Global Cancer Cases, By Percent, By Region, 2012
6. Global Antibody Drug Conjugates Market: By Drug (Adcetris, Kadcyla)
6.1 Global Antibody Drug Conjugates Market-By Drug: Breakdown (%)
6.1.1 Global Antibody Drug Conjugates Market Size and Share, By Drug, 2016
Table 5: Global Antibody Drug Conjugates Market Size and Share, By Drug, 2016
Table 6: Key Drivers
6.1.2 Global Antibody Drug Conjugates Market Size and Share, By Drug, 2022
Table 7: Global Antibody Drug Conjugates Market Size and Share, By Drug, 2022
Table 8: Key Drivers
6.2 Global Adcetris Market Overview
6.2.1 By Value (2012-2016)
Table 9: Global Adcetris Market Size, By Value, 2012-2016 (USD Million)
6.2.2 By Value (2017-2022)
Table 10: Global Adcetris Market Size, By Value, 2017E-2022F (USD Million)
Table A: On-going Clinical Trials of Adcetris
6.3 Global Kadcyla Market Overview
6.3.1 By Value (2013-2016)
Table 11: Global Kadcyla Market Size, By Value, 2013-2016 (USD Million)
6.3.2 By Value (2017-2022)
Table 12: Global Kadcyla Market Size, By Value, 2017E-2022F (USD Million)
7. Global Antibody Drug Conjugates Market: Pipeline Analysis
7.1 By Developer, Phase, Indication and Status
Table B: ADC Pipeline Analysis, (By Drug, Developer, Phase, Indication, Status)
7.2 By Cytotoxic Payload, Linker and Target
Table C: ADC Pipeline Analysis, By Cytotoxic Payload, Linker, Target
8. Global Antibody Drug Conjugates Market: Regional Analysis
8.1 Global Antibody Drug Conjugates Market, By Region: Breakdown (%)
8.1.1 Global Antibody Drug Conjugates Market Size, By Region, 2016 (%)
Table 13: Global Antibody Drug Conjugates Market Size and Share, By Region, 2016
Table 14: Key Drivers
8.1.2 Global Antibody Drug Conjugates Market Size, By Region, 2022 (%)
Table 15: Global Antibody Drug Conjugates Market Size and Share, By Segments, 2022
Table 16: Key Drivers
8.2 North America Antibody Drug Conjugates Market: An Analysis
8.2.1 By Value (2012-2016)
Table 17: North America Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
8.2.2 By Value (2017-2022)
Table 18: North America Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Table 19:Population aged 65 & above, 2011-2015 (% of total)
8.3 North America Antibody Drug Conjugates Market: By Drug
8.3.1 North America Adcetris Market Size, By Value, 2012-2016
Table 20: North America Adcetris Market Size, By Value, 2012-2016 (USD Million)
8.3.2 North America Adcetris Market Size, By Value, 2017E-2022F
Table 21: North America Adcetris Market Size, By Value, 2017E-2022F (USD Million)
8.3.3 North America Kadcyla Market Size, By Value, 2013-2016
Table 22: North America Kadcyla Market Size, By Value, 2013-2016 (USD Million)
8.3.4 North America Kadcyla Market Size, By Value, 2017E-2022F
Table 23: North America Kadcyla Market Size, By Value, 2017E-2022F (USD Million)
8.4 North America Antibody Drug Conjugates Market: Country Analysis (U.S. and Canada)
8.4.1 U.S. Antibody Drug Conjugates Market, By Value (2012-2022)
Table 24: U.S. Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
Table 25: U.S. Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Table 26: Top Cancer in US per 100,000 population, 2013
8.4.2 Canada Antibody Drug Conjugates Market, By Value (2012-2022)
Table 27: Canada Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
Table 28: Canada Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Table 29: Percent Distribution of New Cancer Cases in Males, in Canada, 2016
Table 30: Percent Distribution of New Cancer Cases in Females, in Canada, 2016
8.5 Europe Antibody Drug Conjugates Market: An Analysis
8.5.1 By Value (2012-2016)
Table 31: Europe Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
8.5.2 By Value (2017-2022)
Table 32: Europe Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Table 33: European Country Population Aged 65 and Above, 2011-2015 (% of Total)
Table 34: Cancer Frequency in Europe, By Country, Per 100000 Population, 2012
8.6 Europe Antibody Drug Conjugates Market: By Drug
8.6.1 Europe Adcetris Market Size, By Value, 2012-2016
Table 35: Europe Adcetris Market Size, By Value, 2012-2016 (USD Million)
8.6.2 Europe Adcetris Market Size, By Value, 2017E-2022F
Table 36: Europe Adcetris Market Size, By Value, 2017E-2022F (USD Million)
8.6.3 Europe Kadcyla Market Size, By Value, 2013-2016
Table 37: Europe Kadcyla Market Size, By Value, 2013-2016 (USD Million)
8.6.4 Europe Kadcyla Market Size, By Value, 2017E-2022F
Table 38: Europe Kadcyla Market Size, By Value, 2017E-2022F (USD Million)
8.7 Europe Antibody Drug Conjugates Market: Country Analysis (Germany, France, U.K., & Rest of Europe)
8.7.1 Germany Antibody Drug Conjugates Market, By Value (2012-2022)
Table 39: Germany Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
Table 40: Germany Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Table 41: Estimated Incidences of Cancer in Germany, 2012
Table 42: Estimated Mortality of Cancer in Germany, 2012
8.7.2 France Antibody Drug Conjugates Market, By Value (2012-2022)
Table 43: France Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
Table 44: France Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Table 45: Estimated Incidences of Cancer in France, 2012
Table 46: Estimated Mortality of Cancer in France, 2012
8.7.3 U.K. Antibody Drug Conjugates Market, By Value (2012-2022)
Table 47: U.K. Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
Table 48: U.K. Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Table 49: Estimated Incidences of Cancer in U.K., 2012
Table 50: Estimated Mortality of Cancer in U.K., 2012
8.7.4 Rest of Europe Antibody Drug Conjugates Market, By Value (2012-2022)
Table 51: Rest of Europe Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
Table 52: Rest of Europe Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
8.8 Asia Pacific Antibody Drug Conjugates Market: An Analysis
8.8.1 By Value (2012-2016)
Table 53: Asia Pacific Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
8.8.2 By Value (2017-2022)
Table 54: Asia Pacific Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Table 55: Estimated Cases of Cancer in Asia Pacific, By Country, 2012
8.9 APAC Antibody Drug Conjugates Market: By Drug
8.9.1 Asia Pacific Adcetris Market Size, By Value, 2012-2016
Table 56: Asia Pacific Adcetris Market Size, By Value, 2012-2016 (USD Million)
8.9.2 Asia Pacific Adcetris Market Size, By Value, 2017E-2022F
Table 57: Asia Pacific Adcetris Market Size, By Value, 2017E-2022F (USD Million)
8.9.3 Asia Pacific Kadcyla Market Size, By Value, 2013-2016
Table 58: Asia Pacific Kadcyla Market Size, By Value, 2013-2016 (USD Million)
8.9.4 Asia Pacific Kadcyla Market Size, By Value, 2017E-2022F
Table 59: Asia Pacific Kadcyla Market Size, By Value, 2017E-2022F (USD Million)
8.10 APAC Antibody Drug Conjugates Market: Country Analysis (China, India, Japan and Rest of Asia Pacific)
8.10.1 Japan Antibody Drug Conjugates Market, By Value (2012-2022)
Table 60: Japan Antibody Drug Conjugates Market Size, By Value, 2012-2016 (USD Million)
Table 61: Japan Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Table 62: Japan Population Aged 65 and Above, 2011-2015 (% of Total)
8.10.2 China Antibody Drug Conjugates Market, By Value (2015-2022)
Table 63: China Antibody Drug Conjugates Market Size, By Value, 2015-2016 (USD Million)
Table 64: China Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Table 65: China Population Aged 65 and Above, 2011-2015 (% of Total)
8.10.3 Singapore Antibody Drug Conjugates Market, By Value (2013-2022)
Table 66: Singapore Antibody Drug Conjugates Market Size, By Value, 2013-2016 (USD Million)
Table 67: Singapore Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
8.10.4 India Antibody Drug Conjugates Market, By Value (2015-2022)
Table 68: India Antibody Drug Conjugates Market Size, By Value, 2015-2016 (USD Million)
Table 69: India Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
8.10.5 Rest of Asia Pacific Antibody Drug Conjugates Market, By Value (2013-2022)
Table 70: Rest of Asia Pacific Antibody Drug Conjugates Market Size, By Value, 2013-2016 (USD Million)
Table 71: Rest of Asia Pacific Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
8.11 Rest of the World Antibody Drug Conjugates Market: An Analysis
8.11.1 By Value (2013-2016)
Table 72: Rest of World Antibody Drug Conjugates Market Size, By Value, 2013-2016 (USD Million)
8.11.2 By Value (2017-2022)
Table 73: Rest of World Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
Table 74: Population Aged 65 and Above, By Country, 2011-2015 (% of Total)
8.12 RoW Antibody Drug Conjugates Market: By Drug
8.12.1 Rest of World Adcetris Market Size, By Value, 2013-2016
Table 75: Rest of World Adcetris Market Size, By Value, 2013-2016 (USD Million)
8.12.2 Rest of World Adcetris Market Size, By Value, 2017E-2022F
Table 76: Rest of World Adcetris Market Size, By Value, 2017E-2022F (USD Million)
8.12.3 Rest of World Kadcyla Market Size, By Value, 2013-2016
Table 77: Rest of World Kadcyla Market Size, By Value, 2013-2016 (USD Million)
8.12.4 Rest of World Kadcyla Market Size, By Value, 2017E-2022F
Table 78: Rest of World Kadcyla Market Size, By Value, 2017E-2022F (USD Million)
8.13 RoW Antibody Drug Conjugates Market: Country Analysis (Brazil and South Africa)
8.13.1 Brazil Antibody Drug Conjugates Market, By Value (2014-2022)
Table 79: Brazil Antibody Drug Conjugates Market Size, By Value, 2014-2016 (USD Million)
Table 80: Brazil Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
8.13.2 South Africa Antibody Drug Conjugates Market, By Value (2015-2022)
Table 81: South Africa Antibody Drug Conjugates Market Size, By Value, 2015-2016 (USD Million)
Table 82: South Africa Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
8.13.3 Other Antibody Drug Conjugates Market, By Value (2013-2022)
Table 83: Others Antibody Drug Conjugates Market Size, By Value, 2013-2016 (USD Million)
Table 84: Others Antibody Drug Conjugates Market Size, By Value, 2017E-2022F (USD Million)
9. Market Dynamics
9.1 Drivers
9.2 Challenges
10. Market Trends
11. Porter’s Five Forces Analysis – Antibody Drug Conjugates Market
12. SWOT Analysis –Antibody Drug Conjugates Market
13. Policy and Regulatory Landscape
14. Company Profiling
14.1 F. Hoffmann-La Roche Ltd
Table 85: F. Hoffmann-La Roche Ltd Segmental Break Up
Table 86: F. Hoffmann-La Roche Ltd Geographical Break Up
14.2 Seattle Genetics
14.3 Takeda
Table 87: Takeda Segmental Break Up
Table 88: Takeda Geographical Break Up
14.4 ImmunoGen Inc
14.5 Pfizer Inc.
Table 89: Pfizer Segmental Break Up
Table 90: Pfizer Geographical Break Up
14.6 Sanofi
Table 91: Sanofi Segmental Break Up
Table 92: Sanofi Geographical Break Up
14.7 AbbVie Inc
Table 93: AbbVie Segmental Break Up
Table 94: AbbVie Geographical Break Up
14.8 Cellldex Therapeutics
14.9 Synthon
15.10 Progenics Pharmaceuticals

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report